Operator
Good day, everyone, and welcome to Myovant Sciences first-quarter of fiscal year 2021 earnings conference call. Today s call is being recorded. At this time, I would like to turn the call over to Ryan Crowe, vice president of investor relations at Myovant. Please go ahead.
Ryan Crowe
Vice President of Investor Relations
Thank you, operator. Good morning and thanks for joining us today to review the financial results of Myovant s first quarter of fiscal year 2021 and to discuss other corporate and business updates. Joining me for today s call are Dave Marek, Myovant s chief executive officer; Frank Karbe, president and chief financial officer; Lauren Merendino, chief commercial officer; and Dr. Juan Camilo Arjona, chief medical officer.
Movin On Challenge Design Reveals Top Concepts
- Submissions brought inclusive mobility design with focus on age and disability
- Winning designs announced at Movin On sustainable mobility summit
- Since its inception in 2001, Challenge Design has received more than 14,000 entries from 134 countries
News provided by
Share this article
Share this article
GREENVILLE, S.C., June 3, 2021 /PRNewswire/ Drew Spahn s Crosswing concept took the top spot in the Movin On Challenge Design s 2021 global competition. The New Jersey design student created the concept to address the theme, RESPECT: Ending Isolation and Conquering the Mobility Divide.
The 2021 Movin On Challenge Design brought inclusive mobility ideas from around the world.
Operator
Good day, everyone, and welcome to Myovant Sciences third quarter of fiscal-year 2020 earnings conference call. Today s call is being recorded. At this time, I would like to turn the call over to Ryan Crowe, vice president of investor relations at Myovant. Please go ahead.
Ryan Crowe
Vice President, Investor Relations
Thank you, operator. Good morning, and thanks for joining us today for a general business update and to review the financial results of Myovant s third quarter of fiscal-year 2020. Joining me for today s call are Dave Marek, Myovant s chief executive officer, Frank Karbe, president and chief financial officer; Adele Gulfo, interim chief commercial officer; and Dr. Juan Camilo Arjona, chief medical officer.
Erin Whitney as head of global clinical operations and
Keith White as head of global market access and has also appointed brand strategy consultant
Shauna Horvath to head of global marketing. Whitney joins the team from bluebird bio, while Merck and Genentech veteran White was most recently VP, global market access and pricing at Corbus Pharmaceuticals. Horvath joined Amylyx as a consultant in 2019.
> Culver City, California’s ImmunityBio tapped
Fabio M. Benedetti, M.D., as chief strategy officer, effective Jan. 4. Should ImmunityBio’s NantKwest merger close, Benedetti is expected to assume the role of CSO at the combined company, ImmunityBio said. Benedetti joins from combination therapy specialist Apollomics, where he was chief medical officer.